177 related articles for article (PubMed ID: 16614949)
1. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.
Ogawa M; Nomura S; Car BD; Goldenring JR
Dig Dis Sci; 2006 Mar; 51(3):431-9. PubMed ID: 16614949
[TBL] [Abstract][Full Text] [Related]
2. Reversible drug-induced oxyntic atrophy in rats.
Goldenring JR; Ray GS; Coffey RJ; Meunier PC; Haley PJ; Barnes TB; Car BD
Gastroenterology; 2000 Jun; 118(6):1080-93. PubMed ID: 10833483
[TBL] [Abstract][Full Text] [Related]
3. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
[TBL] [Abstract][Full Text] [Related]
4. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.
Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G362-75. PubMed ID: 15647607
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
6. Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.
Yamagata Y; Aikou S; Fukushima T; Kataoka H; Seto Y; Esumi H; Kaminishi M; Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1254-61. PubMed ID: 23064758
[TBL] [Abstract][Full Text] [Related]
7. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
9. Altered gastric chief cell lineage differentiation in histamine-deficient mice.
Nozaki K; Weis V; Wang TC; Falus A; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1211-20. PubMed ID: 19359424
[TBL] [Abstract][Full Text] [Related]
10. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
11. Antrectomy does not accelerate reversal of omeprazole-induced trophic effects in the rat stomach.
Axelson J; Håkanson R; Sundler F
Scand J Gastroenterol; 1992; 27(3):243-8. PubMed ID: 1502489
[TBL] [Abstract][Full Text] [Related]
12. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
[TBL] [Abstract][Full Text] [Related]
13. Alterations in gastric mucosal lineages before or after acute oxyntic atrophy in gastrin receptor and H2 histamine receptor-deficient mice.
Aikou S; Fukushima Y; Ogawa M; Nozaki K; Saito T; Matsui T; Goldenring JR; Kaminishi M; Nomura S
Dig Dis Sci; 2009 Aug; 54(8):1625-35. PubMed ID: 19507031
[TBL] [Abstract][Full Text] [Related]
14. Effect of mica monomer powder on chief and parietal cells as well as G and D cells in gastric mucosa of chronic atrophic gastritis in rats.
Zhu FS; Si JM; Wang LJ; Wang DF; Chen P
Chin J Integr Med; 2008 Jun; 14(2):111-6. PubMed ID: 18219454
[TBL] [Abstract][Full Text] [Related]
15. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Larsson H; Carlsson E; Håkanson R; Mattsson H; Nilsson G; Seensalu R; Wallmark B; Sundler F
Gastroenterology; 1988 Dec; 95(6):1477-86. PubMed ID: 3181674
[TBL] [Abstract][Full Text] [Related]
16. Oxyntic atrophy, metaplasia, and gastric cancer.
Goldenring JR; Nam KT
Prog Mol Biol Transl Sci; 2010; 96():117-31. PubMed ID: 21075342
[TBL] [Abstract][Full Text] [Related]
17. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole: mode of action and effect on acid secretion in animals.
Wallmark B
Scand J Gastroenterol Suppl; 1989; 166():12-8. PubMed ID: 2557668
[TBL] [Abstract][Full Text] [Related]
19. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
Scott DR; Besancon M; Sachs G; Helander H
Dig Dis Sci; 1994 Oct; 39(10):2118-26. PubMed ID: 7924730
[TBL] [Abstract][Full Text] [Related]
20. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]